Sonnet BioTherapeutics Holdings, Inc. Gains 86.73%

Wed, Mar 16, 2022 at 05:30 PM
Sonnet BioTherapeutics Holdings, Inc. Gains 86.73%

Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ) jumped higher at $0.52, a gain of 86.7%. On Tue, Mar 15, 2022, SONN:NASDAQ hit a New 2-Week Intraday Low of $0.27. The stock got featured on our News Catalysts scanner on Wed, Mar 16, 2022 at 07:52 AM in the 'BIOTECH' category. From Tue, Mar 01, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Wed, Mar 02, 2022 at $0.37 with a volume of 5M+.

About Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ)

Sonnet BioTherapeutics Holdings Inc is a biotechnology company engaged in the development of biologic drugs focused on human antibody binding technology. The firm's pipeline products include SON-080 (low-dose IL-6), SON-081 (low dose IL-6), SON-1010 (IL12-FHAB), and others.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.